DKK3 and prostate carcinoma: For example, it is required for the Dkk-3 inhibition of TGF-β-dependent migration and invasion in PC3 metastatic prostate cancer cells [27], suggesting that this domain might be useful to block the tumor-promoting effects of TGF-β signaling in advanced prostate cancer [27].